← Leaderboards
Beverly A. Mock
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Plasma Cell Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,659,973
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$67,920,434
- Monica M Bertagnolli · Strang Cancer Prevention Center$50,234,377
- Joseph B. Margolick · Johns Hopkins University$42,015,334
- Bharat Thyagarajan · University Of Minnesota$31,496,558
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$26,649,542
Research focus
Plasma Cell NeoplasmGene ExpressionNeoplasm /Cancer GeneticsSite Directed MutagenesisGenetically Modified AnimalsCancer RiskGenetic MappingCyclin Dependent KinaseLaboratory MouseEnzyme InhibitorsNeoplastic ProcessTumor Suppressor ProteinsProtein Structure FunctionCell CycleTissue /Cell CultureDisease /Disorder ModelGenetic SusceptibilityTumor Suppressor GenesMolecular CloningCdkn2a GeneBinding ProteinsComplex Genetic TraitCancer ModelBinding (Molecular Function)
Grant awards (9)
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$406,240
Z01 · FY2008 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$1,243,881
Z01 · FY2007 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumo$0
Z01 · FY2006 · BC · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumo$0
Z01 · FY2005 · BC
Genetics of Susceptibility to Mouse Plasma Cell Tumors$0
Z01 · FY2004 · BC
Genetics of Susceptibility to Mouse Plasma Cell Tumors$0
Z01 · FY2003 · BC
The Genetics of Susceptibility to Mouse Plasma Cell Tumo$0
Z01 · FY2002 · BC
Genetics of Susceptibility to Mouse Plasma Cell Tumors$0
Z01 · FY2001 · BC
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$0
Z01 · FY2000 · BC